LXU FY2025 SEC EDGAR DEF 14A #70 of 168 in industry

Lsb Industries, Inc. CEO pay ratio

The CEO earned $5.4M in FY2025 against median worker pay of $109,467 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-10
Industry
Chemicals & Pharmaceuticals
Industry rank
#70/168

Data updated August 2026

Subscribe to Lsb Industries, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
49:1
Below Average (Scale: 0–1000:1)
CEO pay
$5.4M
Median worker
$109,467

Answer first

Lsb Industries, Inc.'s FY2025 CEO total of $5.4M ranks #902 of 1,423 complete filings; its 49:1 pay ratio ranks #981. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $109,467. Industry placement uses the FY2025 SIC-28 peer cohort (# 70 of 168, 59th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#902
$5.4M of 1,423 FY2025
Ratio rank
#981
49:1 of 1,423
Industry pct
59th
above the industry median pay ratio

How Lsb Industries, Inc. ranks nationally

Lsb Industries, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$5,363,883 37th percentile higher than 37% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Lsb Industries, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($5.4M) against pay ratio (49:1) for Lsb Industries, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both2820634.87652567.612484500.517316433.422148366.341.6:143.6:145.5:147.4:149.4:1CEO total payPay ratio (CEO : median worker)Lsb Industries, Inc., CEO total pay: 5363883 · Pay ratio (CEO : median worker): 49:1Lsb Industries, Inc.Viking Therapeutics, Inc., CEO total pay: 21269833 · Pay ratio (CEO : median worker): 49:1Viking Therapeutics, Inc.Neurocrine Biosciences Inc, CEO total pay: 13448935 · Pay ratio (CEO : median worker): 49:1Neurocrine Biosciences IncAlnylam Pharmaceuticals, Inc., CEO total pay: 14984640 · Pay ratio (CEO : median worker): 48:1Alnylam Pharmaceuticals, Inc.Vaxcyte, Inc., CEO total pay: 14585904 · Pay ratio (CEO : median worker): 48:1Vaxcyte, Inc.Valhi Inc /de/, CEO total pay: 3699168 · Pay ratio (CEO : median worker): 48:1Valhi Inc /de/
Lsb Industries, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Lsb Industries, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Lsb Industries, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
49:1
FY2025
vs prior FY
+10:1
from FY2024 39:1
CEO $ YoY
+24%
$5.4M latest
Filings shown
5
FY2021–2025
Lsb Industries, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $3.5M - $89,904 39:1 -
2022 $3.7M +6.1% $97,925 38:1 -1:1
2023 $4.5M +20% $98,928 45:1 +7:1
2024 $4.3M -2.7% $111,035 39:1 -6:1
2025 $5.4M +24% $109,467 49:1 +10:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 60714, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
49:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$5.4M
Companies in Industry
168
vs. Industry Median
Above
#70 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Lsb Industries, Inc.: MODEST · MID$ pay ratio

Lsb Industries, Inc.'s 49:1 ratio ranks #981 of 1,423 FY2025 complete filings (lower third by ratio). the CEO earned 49× the median employee ($109,467) in FY2025.

Median employee $109,467 (HIGH-MED); MODEST · MID$ stamps put about 49 median-wage years per CEO year.

CEO Total Pay

$5.4M

FY2025 Summary Compensation, below median

Pay Ratio

49:1

Below typical

Lsb Industries, Inc. in the lower-ratio third

Lsb Industries, Inc.'s 49:1 ratio ranks #981 of 1,423 FY2025 complete filings (lower third by ratio). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Lsb Industries, Inc.'s $5.4M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #902 and ratio rank #981 split - treat 49:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$5.4M
Median Employee Pay
$109,467
Pay Ratio
49:1
Filing Date
2026-04-10

Company Info

Ticker
LXU
CIK
60714
Industry
Chemicals & Pharmaceuticals
SIC Code
2810
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 60714, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Lsb Industries, Inc.'s 49:1 ratio ranks #981 of 1,423 FY2025 complete filings (lower third by ratio).

Read with Lsb Industries, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · HIGH-MED.

Peoples Bancorp Inc · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $681 heavier vs Lsb Industries, Inc.); MID · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Zions Bancorporation, National Association /ut/ · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $4K lighter vs Lsb Industries, Inc.); MODEST · HIGH-MED vs this page's MODEST · MID$ · HIGH-MED.
Treace Medical Concepts, Inc. · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $6K heavier vs Lsb Industries, Inc.); MODEST · ELITE-MED vs this page's MODEST · MID$ · HIGH-MED.
Precigen, Inc. · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $10K lighter vs Lsb Industries, Inc.); MODEST · ELITE-MED vs this page's MODEST · MID$ · HIGH-MED.
Viking Therapeutics, Inc. (SIC 28 pole)

Viking Therapeutics, Inc. stamps MODEST · PEAK nearest in-SIC by ABS(pay_ratio) to Lsb Industries, Inc.'s MODEST filing.
National dual ranks · #902/#981

Lsb Industries, Inc.'s FY2025 package sits #902 by CEO dollars and #981 by ratio under MID$ · MODEST.
Ratio primer · MODEST

Lsb Industries, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Lsb Industries, Inc. (CIK 60714), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.